Global Molecular Diagnostics in Infectious Disease Testing Market Insights and Forecast to 2028

Publisher Name :
Date: 02-Mar-2022
No. of pages: 105
Inquire Before Buying

Molecular Diagnostics in Infectious Disease Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics in Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Polymerase Chain Reaction (PCR)

- Isothermal Nucleic Acid Amplification Technology (INAAT)

- Microarrays

- Next-Generation Sequencing (NGS)

- Hybridization

- Others

Segment by Application

- Hospitals

- Clinics

- Academic Institutes

- Laboratories

- Others

By Company

- Abbott

- BD

- BioMerieux

- Thermo Fisher Scientific

- Roche

- Siemens

- Veridex

- Luminex

- GenMark Diagnostics

- Qiagen

- Genomix Biotech

- BioTheranostics

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Molecular Diagnostics in Infectious Disease Testing Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.4 Microarrays
1.2.5 Next-Generation Sequencing (NGS)
1.2.6 Hybridization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2017-2028)
2.2 Molecular Diagnostics in Infectious Disease Testing Growth Trends by Region
2.2.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2021
3.5 Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
6.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type
6.2.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022)
6.2.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028)
6.2.3 North America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application
6.3.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022)
6.3.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028)
6.3.3 North America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
6.4 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country
6.4.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
6.4.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type
7.2.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022)
7.2.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028)
7.2.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application
7.3.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022)
7.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028)
7.3.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
7.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country
7.4.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
7.4.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type
9.2.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022)
9.2.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028)
9.2.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
9.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application
9.3.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022)
9.3.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028)
9.3.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
9.4 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country
9.4.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
9.4.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.2.5 BD Recent Developments
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
11.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.3.5 BioMerieux Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
11.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.5.5 Roche Recent Developments
11.6 Siemens
11.6.1 Siemens Company Details
11.6.2 Siemens Business Overview
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
11.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.6.5 Siemens Recent Developments
11.7 Veridex
11.7.1 Veridex Company Details
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.7.5 Veridex Recent Developments
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.8.5 Luminex Recent Developments
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Details
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.9.5 GenMark Diagnostics Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
11.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.10.5 Qiagen Recent Developments
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Details
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.11.5 Genomix Biotech Recent Developments
11.12 BioTheranostics
11.12.1 BioTheranostics Company Details
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.12.5 BioTheranostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 4. Key Players of Microarrays
Table 5. Key Players of Next-Generation Sequencing (NGS)
Table 6. Key Players of Hybridization
Table 7. Key Players of Others
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2017-2022)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2023-2028)
Table 14. Molecular Diagnostics in Infectious Disease Testing Market Trends
Table 15. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 16. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 17. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 18. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Players (2017-2022)
Table 20. Global Top Molecular Diagnostics in Infectious Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2021)
Table 21. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 25. Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2017-2022)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2023-2028)
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Application (2017-2022)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Application (2023-2028)
Table 35. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 65. Abbott Company Details
Table 66. Abbott Business Overview
Table 67. Abbott Molecular Diagnostics in Infectious Disease Testing Product
Table 68. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 69. Abbott Recent Developments
Table 70. BD Company Details
Table 71. BD Business Overview
Table 72. BD Molecular Diagnostics in Infectious Disease Testing Product
Table 73. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 74. BD Recent Developments
Table 75. BioMerieux Company Details
Table 76. BioMerieux Business Overview
Table 77. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product
Table 78. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 79. BioMerieux Recent Developments
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product
Table 83. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 84. Thermo Fisher Scientific Recent Developments
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Molecular Diagnostics in Infectious Disease Testing Product
Table 88. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 89. Roche Recent Developments
Table 90. Siemens Company Details
Table 91. Siemens Business Overview
Table 92. Siemens Molecular Diagnostics in Infectious Disease Testing Product
Table 93. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 94. Siemens Recent Developments
Table 95. Veridex Company Details
Table 96. Veridex Business Overview
Table 97. Veridex Molecular Diagnostics in Infectious Disease Testing Product
Table 98. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 99. Veridex Recent Developments
Table 100. Luminex Company Details
Table 101. Luminex Business Overview
Table 102. Luminex Molecular Diagnostics in Infectious Disease Testing Product
Table 103. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 104. Luminex Recent Developments
Table 105. GenMark Diagnostics Company Details
Table 106. GenMark Diagnostics Business Overview
Table 107. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product
Table 108. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 109. GenMark Diagnostics Recent Developments
Table 110. Qiagen Company Details
Table 111. Qiagen Business Overview
Table 112. Qiagen Molecular Diagnostics in Infectious Disease Testing Product
Table 113. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 114. Qiagen Recent Developments
Table 115. Genomix Biotech Company Details
Table 116. Genomix Biotech Business Overview
Table 117. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product
Table 118. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 119. Genomix Biotech Recent Developments
Table 120. BioTheranostics Company Details
Table 121. BioTheranostics Business Overview
Table 122. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product
Table 123. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 124. BioTheranostics Recent Developments
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2021 VS 2028
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 4. Microarrays Features
Figure 5. Next-Generation Sequencing (NGS) Features
Figure 6. Hybridization Features
Figure 7. Others Features
Figure 8. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2021 VS 2028
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region: 2021 VS 2028
Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2021
Figure 19. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2021
Figure 21. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 23. North America Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 24. North America Molecular Diagnostics in Infectious Disease Testing Market Size Share by Country (2017-2028)
Figure 25. United States Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 29. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 30. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Share by Country (2017-2028)
Figure 31. Germany Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Share by Region (2017-2028)
Figure 41. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 47. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size Share by Country (2017-2028)
Figure
  • Molecular Diagnostics Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 400
    Molecular Diagnostics Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the molecular diagnostics deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of molecular diagnostics deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics deals. These deals tend to be multicomponent, s......
  • Global Molecular Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 31-Oct-2023        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Molecular Diagnostic market: According to our latest research, the global Molecular Diagnostic market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Molecular D......
  • Global Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology (ISH, PCR, Sequencing, Others), By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)
    Published: 01-Oct-2023        Price: US 2450 Onwards        Pages: 220
    Executive Summary Azoth Analytics has released a research report titled "Global Core Clinical Molecular Diagnostics Market (2023 Edition)" which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical p......
  • Global Molecular Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Sep-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Molecular Diagnostics market: According to our latest research, the global Molecular Diagnostics market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Molecular diagnosis refers to applying molecular biology methods to detect changes in the structure or expression level of genet......
  • Global Molecular Diagnostics in Infectious Disease Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 31-Aug-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Molecular Diagnostics in Infectious Disease Testing market: According to our latest research, the global Molecular Diagnostics in Infectious Disease Testing market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics in Infectious Disease Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time spa......
  • Global Molecular Diagnostics Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 114
    Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes. Market Analysis and Insights: Global Molecular Diagnost......
  • Global Molecular Diagnostics Market 2023
    Published: 13-Aug-2023        Price: US 2450 Onwards        Pages: 89
    Description According to the latest data, the market size of the global satellite imaging for agriculture sector is expected to rise by USD 234.5 million with a CAGR of 6.26% by the end of 2029. The implementation of satellite imaging in agriculture involves utilizing satellites to capture high-resolution images of agricultural land. These images offer valuable data and insights that can be leveraged to improve agricultural systems and enhance farming practices. One of the key......
  • Global Molecular Diagnostics in Infectious Disease Testing Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 129
    The Molecular Diagnostics in Infectious Disease Testing market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Molecular Diagnostics in Infectious Disease Testing industry, and breaks down according to the type, application, and consumption area of Molecular Diagnostics in Infectious Disease Testing. The report also introduces pla......
  • Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Instruments, Software), Application (Respiratory Diseases, HAIs, Cancer, STDs, Hepatitis), Technology (RT-PCR, INAAT), End User (Clinics, Hospitals, ICUs) & Region - Global Forecast to 2028
    Published: 14-Jun-2023        Price: US 4950 Onwards        Pages: 212
    “Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 3.4 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 10.6% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious dise......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs